Rejection Sensitive Dysphoria Test
Explore rejection sensitive dysphoria (RSD) — intense emotional pain from perceived rejection — with a symptom questionnaire and ADHD clinical guide.
What Is Rejection Sensitive Dysphoria?
Rejection Sensitive Dysphoria (RSD) is an intense, often overwhelming emotional response to perceived or actual rejection, criticism, failure, or teasing. The term was popularized by ADHD specialist William Dodson, MD, and is increasingly recognized as a common and highly impairing feature of ADHD, particularly in adults.
The emotional pain of RSD is typically described as sudden, extreme, and disproportionate to the trigger. Unlike borderline personality disorder's fear of abandonment (which is chronic and pervasive), RSD episodes are typically brief, lasting minutes to hours, but can be devastatingly intense while occurring.
RSD is not yet a formal DSM-5-TR diagnosis, but it is widely discussed in clinical ADHD literature and is increasingly studied as a distinct feature of emotional dysregulation in neurodivergent populations.
RSD Symptom Reflection
Rate how often each statement applies to you in general. Consider your overall pattern, not just recent events.
Common patterns people with ADHD-related rejection sensitivity describe:
- Feeling sudden, intense emotional pain when you sense you have been criticized or let someone down
- Anticipating rejection before it happens and changing your behaviour to avoid it (people-pleasing, over-explaining)
- A rapid, overwhelming emotional "crash" following perceived criticism — even from a brief comment or facial expression
- Masking your distress in social or work situations and then experiencing exhaustion or emotional release afterwards
- Replaying interactions repeatedly and interpreting neutral cues as signs of disapproval
- Avoiding situations — relationships, promotions, creative projects — where failure or judgement is possible
These patterns are prompts for reflection and discussion with a clinician, not a scored scale.
Core Features of RSD
Research consistently identifies three interacting features in people with ADHD who report rejection sensitivity.
Intense, bodily emotional pain. Qualitative research (Rowney-Smith et al., 2026) found that participants described rejection sensitivity as generating unpleasant physical sensations alongside emotional distress — a quality that distinguishes it from ordinary social disappointment. The pain is perceived as disproportionate to the trigger and can feel physically as well as emotionally overwhelming.
Masking and concealment. Because the emotional response feels socially unacceptable in intensity, many people develop effortful masking strategies — suppressing visible distress, performing calm, or over-correcting their behaviour. Rowney-Smith et al. found that sustained masking was linked to dissociation from one's own emotional experience and progressive social withdrawal.
Withdrawal and social avoidance. The combination of intense pain and the effort of masking leads many individuals to reduce their social exposure over time. Participants reported pulling back from friendships, career opportunities, and daily activities as a protective strategy. This secondary withdrawal can contribute substantially to functional impairment and loneliness — sometimes exceeding the impairment from core ADHD attention difficulties.
Emotion dysregulation more broadly has been identified by systematic review as a fourth core domain of adult ADHD, associated with greater symptom severity, poorer executive functioning, and higher psychiatric comorbidity (Soler-Gutiérrez et al., 2023).
RSD vs Similar Conditions
Rejection sensitivity and emotional dysregulation appear across several conditions. Accurate differential assessment matters because the most effective interventions differ.
| Feature | ADHD with RSD | Borderline personality disorder | Bipolar disorder | Social anxiety disorder |
|---|---|---|---|---|
| Onset | Childhood neurodevelopmental | Typically emerges in adolescence; linked to adverse early experiences | Episodic; mood states persist days–weeks | Often childhood/adolescence |
| Emotional episodes | Brief (minutes to hours); triggered by perceived rejection/criticism | More pervasive and chronic; linked to fear of abandonment | Sustained mood episodes not tied to social triggers | Anticipatory fear predominates; avoidance pattern |
| Core fear | Being rejected, criticized, or seen as failing | Abandonment; identity instability | Not primarily rejection-based | Humiliation or negative evaluation in social contexts |
| Impulsivity | Present (ADHD core feature) | Present; may involve self-harm | Present during manic/mixed phases | Not a primary feature |
| Childhood ADHD symptoms | Present by definition | Not required; ADHD often comorbid | Not required | Not required |
| Stable sense of self | Generally intact | Markedly unstable | Generally intact between episodes | Generally intact |
ADHD and borderline personality disorder are highly comorbid in adult populations, sharing features of impulsivity and emotional dysregulation (Weiner et al., 2019). BPD is characterized by more severe trait-level emotion regulation difficulties, whereas ADHD is characterized by more severe trait impulsivity (Weiner et al., 2019). Symptoms specific to BPD and not typical of ADHD alone include chronic feelings of emptiness, suicidal behaviour, self-harm, and stress-related dissociation (Asherson et al., 2014).
Adults with ADHD also have substantially elevated rates of anxiety disorders and major depressive disorder compared with the general population (Hartman et al., 2023). Social anxiety disorder, in particular, can appear to overlap with RSD because both involve distress around social evaluation — but social anxiety is characterized by anticipatory fear and avoidance rather than the sudden, post-trigger emotional crash typical of RSD.
The ADHD–RSD Connection
RSD is thought to arise from the same dysregulation of the norepinephrine and dopamine systems that underlies ADHD attention and impulse control difficulties. The emotional dysregulation in ADHD, including RSD, is neurologically driven, not a character flaw.
Emotion dysregulation is widely reported in clinical ADHD settings and is frequently described by adults with ADHD as among the most impairing aspects of their condition — sometimes more disruptive to relationships and career than inattention or hyperactivity alone. Episodes can recur multiple times in a single day in response to different triggers.
The neurodevelopmental basis of ADHD-related emotion dysregulation is supported by the World Federation of ADHD Consensus Statement (Faraone et al., 2021), which confirmed emotion dysregulation as a well-evidenced feature of the disorder across the lifespan. Direct evidence specifically linking rejection sensitivity to ADHD is more mixed — in one study of young adult men, those with ADHD did not show significantly higher rejection sensitivity than peers without ADHD, though both ADHD subtypes reported lower general self-esteem and the predominantly inattentive group reported worse relational outcomes (Canu & Carlson, 2007). This suggests that ADHD-related social difficulties are not solely mediated through rejection sensitivity, and that individual presentations vary substantially.
Treatment Approaches
There is no treatment approved specifically for RSD. Clinical management focuses on addressing the underlying ADHD-related emotional dysregulation, using a combination of pharmacological and psychological approaches.
ADHD medication. Stimulant medications (methylphenidate, amphetamine) and non-stimulant options used in ADHD management have established evidence for improving attention and impulse control; their effect on emotional dysregulation is less directly studied but clinically reported. Medication does not eliminate rejection sensitivity but may reduce the immediacy and intensity of emotional reactivity.
Cognitive-behavioural therapy (CBT). A Cochrane systematic review (Lopez et al., 2018) found that CBT produced significant improvements in core ADHD symptoms when compared with waiting-list controls, with additional benefits for self-reported depression and anxiety. CBT combined with medication outperformed medication alone. While emotional dysregulation is not the primary outcome measure in most ADHD-CBT trials, acquiring skills for recognizing and challenging automatic negative interpretations of social situations is directly relevant to RSD patterns.
Dialectical behaviour therapy (DBT) skills. DBT-based approaches, originally developed for borderline personality disorder, address emotion regulation, distress tolerance, and interpersonal effectiveness — all directly applicable to RSD. DBT-based psychotherapy has evidence in both BPD and adult ADHD contexts (Philipsen, 2006). It is particularly useful when emotional dysregulation is severe or when ADHD co-occurs with BPD traits.
Psychoeducation and self-compassion. Understanding that RSD is a neurologically mediated feature — not a personality weakness — reduces shame and helps individuals communicate their experiences to family, partners, and colleagues. Self-compassion practices and structured skills training can meaningfully improve daily function even before significant symptom change occurs.
Treatment planning should be guided by a qualified clinician who can assess which conditions are present, what the relative contribution of each is, and how to sequence interventions appropriately.
Track Emotional Dysregulation Clinically
HiBoop helps ADHD and mental health practices monitor emotional dysregulation alongside core ADHD symptoms, providing a complete picture of treatment response over time.
Frequently Asked Questions
What is rejection sensitive dysphoria?
Rejection sensitive dysphoria (RSD) is an intense, sudden emotional response to perceived or actual rejection, criticism, or failure. It is most often discussed in the context of ADHD, where emotional dysregulation is increasingly recognized as a core feature. RSD is not a formal DSM-5-TR diagnosis but is widely used in clinical ADHD practice to describe these experiences.
Is RSD only found in people with ADHD?
RSD is primarily discussed in ADHD contexts because emotional dysregulation is a well-documented feature of the condition. However, heightened rejection sensitivity can also appear in borderline personality disorder, social anxiety disorder, and mood disorders, making careful differential assessment important. A qualified clinician can help distinguish which condition best accounts for the pattern.
Can this questionnaire diagnose RSD or ADHD?
No. This questionnaire is a self-reflection tool only. It is not a validated diagnostic instrument and cannot diagnose RSD, ADHD, or any other condition. If you recognize strong patterns here, discuss them with a mental health professional who can carry out a thorough assessment.
Can RSD be treated?
There is no RSD-specific approved treatment. Clinicians typically address RSD as part of the broader management of ADHD-related emotional dysregulation. Evidence-based approaches include ADHD medication, cognitive-behavioural therapy (CBT), and dialectical behaviour therapy (DBT) skills, all of which have shown benefit for emotional regulation difficulties in adults with ADHD.
References
- 1.Soler-Gutiérrez AM, Pérez-González JC, Mayas J. Evidence of emotion dysregulation as a core symptom of adult ADHD: A systematic review. PLoS One. 2023;18(1):e0280131.View source
- 2.Rowney-Smith A, Sutton B, Quadt L, Eccles JA. The lived experience of rejection sensitivity in ADHD – A qualitative exploration. PLoS One. 2026;21(1):e0314669.View source
- 3.Canu WH, Carlson CL. Rejection sensitivity and social outcomes of young adult men with ADHD. J Atten Disord. 2007;10(3):261-75.View source
- 4.Weiner L, Perroud N, Weibel S. Attention Deficit Hyperactivity Disorder and Borderline Personality Disorder in adults: a review of their links and risks. Neuropsychiatr Dis Treat. 2019;15:3115-3129.View source
Bill this assessment
The Rejection Sensitive Dysphoria Test qualifies for reimbursement under these CPT codes (US).
Last reviewed: Jun 3, 2026
Related Assessments
Explore complementary clinical tools and screeners